Thus, in tumours in which Nrf2 is constitutively unregulated, inhibition of MKP-1 represents a potentially useful therapeutic approach to overcome drug resistance and inhibit cell proliferation in NSCLC. The gene discussed is DUSP1; the disease is non-small cell lung carcinoma.